We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Seroquel XR Gets New Bipolar Disorder Indications
Seroquel XR Gets New Bipolar Disorder Indications
October 10, 2008
The FDA approved AstraZeneca’s psychotropic drug Seroquel XR for three new indications for bipolar disorder, bringing the product’s approved uses in line with the immediate-release formulation of the drug.